Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02444637

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
National Neuroscience Institute (from the registry)
Registry
  • NCT NCT02444637
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Singapore (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02444637. Allocation not applicable; no masking; primary purpose treatment. Start 2015-04 (actual); primary completion 2019-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD
Condition
Alzheimer Disease
Condition
CVA (Cerebrovascular Accident)
Intervention (Drug)
Rivastigmine
Lead sponsor
National Neuroscience Institute (class: other)

Record details

Record id
cardio:ct-nct02444637
Content hash
cb18e5715827a5729f3e0200defba243b64cd3e3293f85dc698ac9befbf38acb